de Smet P A, Fischer H R
Wetenschappelijk Instituut Nederlandse Apothekers, Den Haag.
Ned Tijdschr Geneeskd. 2000 Jun 17;144(25):1206-9.
In daily practice the optimal time of administration of sulphonylurea derivatives is not always clear. Administration 30 minutes prior to meals allegedly offers the advantage that an active plasma level has been reached when food enters the gastrointestinal tract. Alleged disadvantages are higher risk of hypoglycaemia and poor compliance. In publications from Medline 1966-1999 the 24-hour availability of sulphonylurea derivates was the same after administration at different times. The absorption rate of glibenclamide and tolbutamide was not affected by food. Study results concerning gliclazide were contradictory. The absorption rate of glipizide was reduced after ingestion during breakfast. In several, partly the same, small studies the findings concerning the variation of the glucose level in time in patients with type 2 diabetes mellitus were equivocal. The pharmacokinetic and pharmacodynamic evidence that sulphonylurea derivatives should be taken 30 minutes before meals appears to be so limited that in our opinion it is out-weighed by the potential risk that this advice may compromise the drug compliance of users.
在日常实践中,磺脲类衍生物的最佳给药时间并不总是明确的。据称,饭前30分钟给药的优势在于当食物进入胃肠道时已达到有效的血浆水平。所谓的缺点是低血糖风险较高以及依从性差。在1966年至1999年Medline的出版物中,磺脲类衍生物在不同时间给药后的24小时可利用度是相同的。格列本脲和甲苯磺丁脲的吸收速率不受食物影响。关于格列齐特的研究结果相互矛盾。早餐期间服用后,格列吡嗪的吸收速率降低。在一些部分相同的小型研究中,关于2型糖尿病患者血糖水平随时间变化的研究结果并不明确。磺脲类衍生物应在饭前30分钟服用的药代动力学和药效学证据似乎非常有限,以至于在我们看来,这一建议可能会影响使用者的药物依从性,其潜在风险超过了上述证据。